# Kasper Rossing

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/kasper-rossing/

## Facts

| Field | Value |
| --- | --- |
| Citations | 7,201 |
| Field | Chronic Kidney Disease and Diabetes |
| h-index | 40 |
| i10-index | 71 |
| Last Known Institution | University of Copenhagen |
| OpenAlex ID | https://openalex.org/A5077987218 |
| ORCID iD | 0000-0002-5253-1247 |
| Works | 126 |

## Researcher papers

- [Naturally Occurring Human Urinary Peptides for Use in Diagnosis of Chronic Kidney Disease](https://scholariq.org/papers/naturally-occurring-human-urinary-peptides-for-use-in-diagnosis-of-chronic/)
- [Decreasing Incidence of Severe Diabetic Microangiopathy in Type 1 Diabetes](https://scholariq.org/papers/decreasing-incidence-of-severe-diabetic-microangiopathy-in-type-1-diabetes/)
- [Progression of nephropathy in type 2 diabetic patients](https://scholariq.org/papers/progression-of-nephropathy-in-type-2-diabetic-patients/)
- [2025 ESC Guidelines for the management of myocarditis and pericarditis](https://scholariq.org/papers/2025-esc-guidelines-for-the-management-of-myocarditis-and-pericarditis/)
- [Clinical proteomics: A need to define the field and to begin to set adequate standards](https://scholariq.org/papers/clinical-proteomics-a-need-to-define-the-field-and-to-begin-to-set-adequate/)
- [Beneficial Effects of Adding Spironolactone to Recommended Antihypertensive Treatment in Diabetic Nephropathy](https://scholariq.org/papers/beneficial-effects-of-adding-spironolactone-to-recommended-antihypertensive/)
- [Urinary Proteomics in Diabetes and CKD](https://scholariq.org/papers/urinary-proteomics-in-diabetes-and-ckd/)
- [Quantitative Urinary Proteome Analysis for Biomarker Evaluation in Chronic Kidney Disease](https://scholariq.org/papers/quantitative-urinary-proteome-analysis-for-biomarker-evaluation-in-chronic/)
- [Beneficial impact of spironolactone in diabetic nephropathy](https://scholariq.org/papers/beneficial-impact-of-spironolactone-in-diabetic-nephropathy/)
- [Dual blockade of the renin-angiotensin system versus maximal recommended dose of ACE inhibition in diabetic nephropathy](https://scholariq.org/papers/dual-blockade-of-the-renin-angiotensin-system-versus-maximal-recommended-dose-of/)

## Researcher topics

- [Chronic Kidney Disease and Diabetes](https://scholariq.org/topics/chronic-kidney-disease-and-diabetes/)
- [Heart Failure Treatment and Management](https://scholariq.org/topics/heart-failure-treatment-and-management/)
- [Mechanical Circulatory Support Devices](https://scholariq.org/topics/mechanical-circulatory-support-devices/)
- [Blood Pressure and Hypertension Studies](https://scholariq.org/topics/blood-pressure-and-hypertension-studies/)
- [Cardiovascular Function and Risk Factors](https://scholariq.org/topics/cardiovascular-function-and-risk-factors/)

## Researcher university

- [University of Copenhagen](https://scholariq.org/institutions/university-of-copenhagen/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.